DOX has been shown to inhibit proliferation of cancer cells through proteolytic activation of CREB3L1 (cyclic AMP [cAMP] response element-binding protein 3-like 1), a transcription factor synthesized as a membrane-bound precursor. The gene discussed is CREB3L1; the disease is cancer.